First Trust Nasdaq Lux Digital Health Solutions ETF (EKG)

The First Trust Nasdaq Lux Digital Health Solutions ETF (EKG) holds companies focused on the technology side of medicine—the software, hardware, and platforms reshaping how people manage their health and how healthcare systems operate. The fund tracks the Nasdaq Lux Digital Health Solutions Index, a rules-based benchmark of companies across digital health innovation.

What counts as digital health here? Telemedicine platforms that let patients see doctors from home. Data analytics and AI companies that help hospitals manage patient records, allocate beds, and optimise workflows. Wearable devices that monitor vital signs and detect early warning signs. Digital therapeutics—apps that treat disease rather than just tracking it. Software companies powering clinic management, pharmacy systems, electronic health records, and health insurance administration. The index spans roughly 40–50 stocks from this ecosystem, weighted by market capitalisation. The fund is not about brick-and-mortar hospitals or traditional insurance companies, but the enablers and disruptors of healthcare delivery.

Digital health emerged as a distinct investment theme during the pandemic, when lockdowns forced remote care and telemedicine adoption exploded. Many of those habits persisted even as life normalised. The underlying thesis is straightforward: software and connected devices can make healthcare more convenient, more data-driven, and more accessible in places where physical clinics are scarce. Health data platforms are valuable because hospitals and insurers sit on mountains of patient information but struggle to extract actionable insight. Wearables have evolved from novelties—step counters, fitness trackers—into medically useful devices that can detect irregular heartbeats and other early warning signs. Together, these technologies represent a shift in the locus of care, away from episodic visits to hospitals and toward continuous, remote monitoring and digital-first intervention.

But this is a young sector with real challenges. Many digital health companies are not yet profitable. Regulations vary wildly by country and shift fast: rules about what telemedicine platforms must do, how they handle patient data privacy, and how they get reimbursed by insurance are still being written in most jurisdictions. Companies have seen share prices plummet when growth slowed faster than expected or when reimbursement rates fell by regulatory decree. Investors in EKG should expect volatility and be comfortable holding companies in the innovation phase rather than the cash-cow phase—many holdings are fighting for viability, not yet dominant incumbents.

The fund’s mechanics and costs

First Trust Advisors manages EKG as a passive, index-tracking fund. There is no stock-picker trying to beat the index; the portfolio simply follows the index rules. The expense ratio is moderate for a sector ETF—typically under 0.65 percent annually. EKG trades on US exchanges with reasonable daily volume, so buying and selling is straightforward and does not move the price significantly.

The index composition is dynamic. Periodic rebalancing means holdings that grow too large relative to the index get trimmed, and companies that fall out of favour with the index rules are rotated out. Watching the composition over time tells you whether the fund’s character is shifting—towards larger, more mature incumbents versus newer growth companies.

Competitive intensity and risks

Competition in digital health is fierce. Telemedicine platforms compete on price, convenience, and network effects. Health data companies race to build the most useful analytics for hospital systems. Device makers navigate FDA regulations, reimbursement codes, and rapid technological change. Because many holdings are unproven, profitability is irregular. A failed product launch or missed growth target can crater the stock. The sector is also capital-intensive and still awash in venture funding, creating the risk that private funding dries up if investor sentiment shifts.

EKG is suitable for long-term investors with a clear thesis that digital health is durable and will reshape medicine over the next decade. It is not traditional healthcare or pharmaceutical exposure; those are different bets. It is for investors who believe rural patients will consult specialists via app, hospitals will use AI to manage resources efficiently, and that patient care will become increasingly software-first and decoupled from geography.

Research EMCB by starting with the prospectus and holdings on First Trust’s website. Understand the index methodology and current composition. Watch the holdings for changes; if your names are being dropped, the fund’s character shifts. Assess the largest holdings for unit economics and regulatory exposure, because the sector is young and each player is still proving viability.